Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
See intermediate care facility (ICF) See intermediate care facility (ICF) The Trend Toward Long-Term Care
ideal drug therapy
imitation drugs, misbranding
importation of drugs
incident reporting
indictment
individual practitioners Records Required of Individual Practitioners defined
information asymmetry
Ingram v. Hook's Drug (1985)
ingredients labeling and nonprescription drug labeling active misbranding prescription drugs
injury to competition
In re Brand Name Prescription Drugs Antitrust Litigation (1996)
In re Pharmaceutical Industry Average Wholesale Price Litigation (2009)
inserts, patient packages
inspections DEA inspections overview of state pharmacy boards constitutional requirements Inspections Under the Federal Food, Drug, and Cosmetic Act practical considerations
institutional practitioner, defined
institutional review board (IRB)
insurance, for malpractice
interactive promotional media
Internet pharmacies, regulation of
Internet prescriptions Section 502(b)(2) rules dispensing regulations validity of
interns, regulation of
Interstate Commerce Clause Constitution State Authority to Regulate State vs Federal Authority
In the Case of Daniel Family Pharmacy (1999) Daniel Family Pharmacy Dispensing of Schedule III, IV, and V Controlled Substances
In the Matter of CVS Pharmacy Wayne (1989) In the Matter of CVS Pharmacy Wayne State Advertising Laws: The Virginia Case and the First Amendment
In the Matter of Sobel v. Board of Pharmacy (1994)
inventory records, recordkeeping
investigational drugs access to - united states V. rutherford individual patient access to widespread patient treatment with access to expedited approval of drugs Individual Patient Access to Investigational Drugs for Serious Diseases (Parallel Track Policy) (§ 561)
Investigational New Drug (IND) Pharmacy Compounding vs Manufacturing application
See institutional review board (IRB) See institutional review board (IRB) The Road to an Approved New Drug Application